Day: March 13, 2024

Paris, France – March 13, 2024 – A Franco-Singaporean collaboration has been announced to benchmark and optimize the energy efficiency of quantum computing. The partnership includes Eviden, the Atos Group business leading in advanced computing, A*STAR’s Institute of High Performance Computing (IHPC) in Singapore, and MajuLab, an international research laboratory in quantum physics. Majulab is a joint laboratory of the Centre National de la Recherche Scientifique (CNRS), Université Côte d’Azur (UCA), Sorbonne University (SU), National University of Singapore (NUS) and Nanyang Technological University (NTU). In the context of conventional high-performance computing (HPC) environments, energy optimizations are generally achieved through improved hardware architectures and better cooling systems. However new approaches must be set up to optimize...

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules of 2,223,333 shares of common stock (or pre-funded warrants in lieu thereof), Series H-1 warrants to purchase up to an aggregate of 2,223,333 shares of common stock and Series H-2 warrants to purchase up to an aggregate of 2,223,333 shares of common stock, at a combined purchase price of $4.55 per share of common stock (or pre-funded warrant) and associated Series H-1 warrants and Series H-2 warrants. The gross proceeds to INBS from the private placement were approximately $10.1 million,...